Experts Cull Financial Lessons From 'Game of Thrones'
10 Tricks Grocers Use to Get You to Spend More Money
The Next Big Automotive Boom: Super-Luxury SUVs
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.